Advertisement
Advertisement

ANVS

ANVS logo

Annovis Bio, Inc.

2.66
USD
Sponsored
-0.15
-5.23%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

2.67

+0.01
+0.26%

ANVS Earnings Reports

Positive Surprise Ratio

ANVS beat 10 of 20 last estimates.

50%

Next Report

Date of Next Report
Mar 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.35
Implied change from Q3 25 (Revenue/ EPS)
--
/
-5.41%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-18.60%

Annovis Bio, Inc. earnings per share and revenue

On Nov 12, 2025, ANVS reported earnings of -0.37 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -18.93% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +15.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.35 USD, with revenue projected to reach -- USD, implying an decrease of -5.41% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Annovis Bio, Inc. reported EPS of -$0.37, missing estimates by -18.93%, and revenue of $0.00, 0% as expectations.
The stock price moved up 15.17%, changed from $2.11 before the earnings release to $2.43 the day after.
The next earning report is scheduled for Mar 19, 2026.
Based on 5 analysts, Annovis Bio, Inc. is expected to report EPS of -$0.35 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement